Table 6.
Compound | Antiherpetic and Cytotoxicity Assays, Strains, Cells, and Reference Agents | Results | Additional Information | Source |
---|---|---|---|---|
Bacteriocins (semi-purified) |
Vero cells, HSV-1 (strain EK) CPE Viral adsorption assay |
Before adsorption IC50 235.6 μg/mL, SI 4.6 (for GEn14) After adsorption IC50 24.0 μg/mL, SI 17.8 (for GEn17) |
Bacteria from goat milk Enterococcus durans (GEn09, GEn12, GEn14, and GEn17). | [108] |
Subtilosin | Vero cells, HSV-2 (strain G) PRA Virucidal assay Time-of-addition assay Indirect immunofluorescence assay |
At 200 μg/mL a reduction over 99.9% in virus titer EC50 18.2 μg/mL, SI 17.4 |
Bacillus amyloliquefaciens Cyclic peptide Antiviral and virucidal effect. This compound affects late stages of the viral replicative cycle such as viral glycoprotein intracellular transport. |
[109] |
Simplicilliumtide J | Vero cells, HSV-1 PRA ACV IC50 3.0 µM |
IC50 14.0 µM | Deep-Sea-Derived Fungus Simplicillium obclavatum Cyclic peptides |
[110] |
Verlamelin A | IC50 16.7 µM | |||
Verlamelin B | IC50 15.6 µM | |||
Aspergillipeptide D | Vero cells, HSV-1 (strain 15577, ACV resistant clinical isolates HSV-1-106 and HSV-1-153) CPE ACV IC50 3 µM |
HSV-1 (strain 15577) IC50 9.5 µM | Marine gorgonian-derived fungus Aspergillus sp. No cytotoxicity at concentrations tested. Aspergillipeptide D showed activity against acyclovir-resistant HSV-1-106 and HSV-1-153. |
[111] |
Aspergillipeptide E | HSV-1 (strain 15577) IC50 19.8 µM | |||
RC28 (28.25 kDa) protein | BGMK cells, HSV-1 (KOS) CPE |
IC50 0.078 mg/mL, SI > 32 | Edible mushroom Rozites caperata (Cortinarious caperata) | [112] |
Pa-MAP | Vero cells, HSV-1 Virus titer reduction method Virucidal assay ACV at 20 μg/mL PI 99% |
EC50 83 μg/mL, SI ˃ 5 | Polar fish Pleuronectes americanus | [113] |
Bovine lactoperoxidase | Vero cells, HSV-1 PRA |
At 0.5 mg/mL 100% antiviral effect | Milk hemoprotein | [114] |
Griffithsin | Vero cells, HeLa cells, HSV-2 (strain G) PrestoBlue cell viability reagent - reading of fluorescence Flow cytometry Inhibition of adsorption assay In vivo HSV-2 murine model |
EC50 5.8 μg/mL (230 nM) Griffithsin/carrageenan combination EC50 3.4 ng/mL |
Red alga Griffithsia A lectin with high affinity for mannose-rich N-linked glycans. Griffithsin may block viral entry by binding to HSV-2 glycoprotein D. The griffithsin/carrageenan combination product but not GRFT or CG alone, reduced HSV-2 vaginal infection in mice when given an hour before challenge. |
[115] |
Melittin | Vero cells, HSV-1 Virus yield inhibition assay |
EC50 1.35 μM; SI 6.3 | Cationic 26 amino acids peptide isolated from insects—the main component of bee venom | [116] |